Rella W, Winterleitner H, Pawlowski J, Kummer M, Krepler P
Onkologie. 1978 Jun;1(3):113-8. doi: 10.1159/000213930.
The response to phytohemagglutinin (PHA) of lymphocytes from 62 children with acute lymphoblastic leukemia (ALL) was tested before and during cytostatic therapy. Nineteen patients were tested as well for reactivity in autologous mixed lymphocyte-blast cell cultures. The prognostic value of the results obtained has been assessed. Children remained longer in their first complete remission 1) if the response to PHA before therapy was normal or only slightly diminished, or 2) if it returned to normal as soon as complete remission was attained, and 3) if periodic intensification therapy was followed by a rebound in spontaneous lymphocyte proliferation. The stimulatory response to PHA during maintenance therapy and the reactivity in mixed lymphocyte- blast cell cultures were not helpful prognostic criteria. In conclusion, determination of the PHA responsiveness at specific times, i.e. before therapy, after remission induction and after periodic intensification therapy, could help identify poor risk patients in ALL.
对62例急性淋巴细胞白血病(ALL)患儿在进行细胞抑制治疗前及治疗期间,检测了其淋巴细胞对植物血凝素(PHA)的反应。对19例患者还检测了自体混合淋巴细胞-母细胞培养中的反应性。已评估所获结果的预后价值。患儿首次完全缓解期维持较长时间的情况为:1)若治疗前对PHA的反应正常或仅略有降低;2)若一旦达到完全缓解其反应即恢复正常;3)若定期强化治疗后自发淋巴细胞增殖出现反弹。维持治疗期间对PHA的刺激反应及混合淋巴细胞-母细胞培养中的反应性并非有用的预后标准。总之,在特定时间,即治疗前、缓解诱导后及定期强化治疗后测定PHA反应性,有助于识别ALL中的高危患者。